|The HLA-ABC n/a (Catalog #MBS520339) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The Anti-Human HLA-ABC, Purified, (Clone W6/32 HLK) (mouse IgG2a) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s HLA-ABC can be used in a range of immunoassay formats including, but not limited to, Immunohistochemistry (IHC), Cytotoxic Assay (CA), Immunoprecipitation (IP).
immunoprecipitation, flow cytometry, complement dependent cytotoxicity and functional assays. Researchers should empirically determine the suitability of the HLA-ABC n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the Anti-Human HLA-ABC, Purified, (Clone W6/32 HLK) (mouse IgG2a) with the following immunoassay(s):
anti-human HLA-ABC monoclonal antibody recognizes an epitope common among 43 kDa chains of the HLA-ABC antigens. These antigens appear on virtually every human nucleated cell. This antibody is suitable as a positive control for HLA tissue typing and crossmatching.
Immunogen: Purified membrane of human tonsil cells
Donor: BALB/c spleen
Fusion Partner: NS1/1-Ag4.1. Presentation: Purified IgG buffered in PBS and 0.02% NaN3. (Purified from ascitic fluid via Protein G Chromatography). For maximum recovery of contents, spin down tube before use. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing HLA-ABC are readily searchable from our website. Different antibodies against the same target such as HLA-ABC may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.